Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine.

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions
Headache (Migraine)
Interventions
DRUG

Lornoxicam 8 mg

DRUG

Lornoxicam 16 mg

DRUG

Placebo

Trial Locations (23)

19107

Jefferson Headache Center, Philadelphia

22304

The Innovative Clinical Research Center, Alexandria

27401

Headache Wellness Center, Greensboro

27599

University Headache Center, Chapel Hill

27607

North Carolina Clinical Research, Raleigh

33407

Premiere Research Institute, West Palm Beach

33709

Meridien Research, St. Petersburg

35235

Alabama Clinical Therapeutics, Birmingham

36693

University of South Alabama Neurology, Mobile

37203

Clinical Research Associates, Inc., Nashville

48104

Michigan Head Pain and Neurological Institute, Ann Arbor

55441

Clinical Research Institute, Plymouth

60614

Diamond Headache Clinic, Chicago

63141

Mercy Health Reserach / Ryan Headache Center, St Louis

65807

Headache Care Center, Springfield

72205

Little Rock Family Practice Clinic, Little Rock

77004

Houston Headache Clinic, Houston

84124

Jean Brown Research, Salt Lake City

90404

California Medical Clinic for Headache, Santa Monica

92660

C. Phillip O'Carroll, MD, Inc., Newport Beach

98104

Swedish Pain Center, Seattle

06902

New England Center for Headache, Stamford

02747

NE Medical Research Associates, Inc., North Dartmouth

Sponsors

Lead Sponsor

All Listed Sponsors
lead

POZEN

INDUSTRY